Acutaas Chemicals Shares Surge 13% to Record High Following Strong Q2 Earnings

Market Performance

Acutaas Chemicals shares experienced a significant rally, climbing 13 percent to reach a record intraday high of ₹3,797 on the National Stock Exchange (NSE). This performance stood out amidst a generally muted market environment, where the Nifty 50 index saw a decline of 0.26 percent. The current stock price surpasses the previous record of ₹3,735 established in July 2026. Year-to-date, the company’s stock has appreciated by 116 percent.

Financial Highlights for Q2FY27

The company reported robust financial results for the quarter ended September 2026:

• Revenue: ₹436.9 crore, marking a 42.7 percent year-on-year (YoY) increase.
• EBITDA: ₹176.0 crore, up 84.6 percent YoY, with margins expanding to 40.3 percent from 31.1 percent.
• Profit After Tax (PAT): ₹123.1 crore, representing a 71.4 percent YoY growth.

Strategic Developments and Guidance

Management attributed the strong results to momentum in the pharmaceutical intermediates business. A key strategic milestone reached during the quarter was the early inauguration of a new manufacturing facility in South Korea, designed to support semiconductor applications including photo resists and packaging materials.

Following these results, the company has updated its outlook:

• Revenue Growth Guidance: Increased from 25 percent to approximately 30 percent for FY27.
• EBITDA Margin Guidance: Revised to a range of 38-40 percent.

Industry Outlook

Acutaas Chemicals operates within the growing Indian CDMO and semiconductor supply chain sectors. The company noted that India’s strategic focus on diversifying global supply chains (the China+1 strategy) and government-backed initiatives, such as the PLI scheme for semiconductors, are expected to provide sustained tailwinds for the domestic chemical industry.

*Investors can verify these financial results and management commentary by visiting the official corporate filings section on the National Stock Exchange website.*